Actions

Extra: Difference between revisions

From haematologyetc.co.uk

No edit summary
No edit summary
Line 5: Line 5:
:<span style="color:navy">'''Summary'''</span>
:<span style="color:navy">'''Summary'''</span>


:Although CD15 is expressed in a range of haematological cell types, the main practical use for the marker is in the recognition of cells that have granulocytic or monocytic features. For this reason CD15 has a role in lineage distinction in AML. CD15 was originally described as the Lewis blood group antigen: Sialyl Lewis X. Deficiency of CD15 causes the clinical disorder Leukocyte Adhesion Deficiency Type 2.
:The main practical use for CD15 is for the recognition of cells that have granulocytic or monocytic features. For this reason CD15 has a role in lineage distinction in AML. CD15 is however also expressed in a range of haematological cell types and was originally described as the Lewis blood group antigen: Sialyl Lewis X.  
 


</div>
</div>


Line 13: Line 13:
:<span style="color:navy">'''Background'''</span>
:<span style="color:navy">'''Background'''</span>


:CD15 is a carbohydrate important in the initial phases of cell-to-cell adhesion known in this context as e-selectin .  
:CD15 is a carbohydrate important in the initial phases of cell-to-cell adhesion known in this context as E-selectin. In normal cells CD15 is constitutively expressed by granulocytes and monocytes, but not by resting lymphocytes - although induced strongly following activation. Deficiency of CD15 causes the clinical disorder Leukocyte Adhesion Deficiency Type 2.
 




:<span style="color:navy">'''Diagnostic Use'''</span>
:<span style="color:navy">'''Diagnostic Use'''</span>


*xxxxx
*In histopathology CD15 is important in the recognition of the Redd Sterberg cells of Hodgkin Lymphoma
*CD15 is expressed by most cases of AML that have granulocytic or monocytic differentiation where expression may vary within the population.
*CD15 should not however be regarded as an exclusive myeloid marker since it is expressed by some cases of CLL and ALL 






-----
-----

Revision as of 09:56, 30 May 2023


Summary
The main practical use for CD15 is for the recognition of cells that have granulocytic or monocytic features. For this reason CD15 has a role in lineage distinction in AML. CD15 is however also expressed in a range of haematological cell types and was originally described as the Lewis blood group antigen: Sialyl Lewis X.



Background
CD15 is a carbohydrate important in the initial phases of cell-to-cell adhesion known in this context as E-selectin. In normal cells CD15 is constitutively expressed by granulocytes and monocytes, but not by resting lymphocytes - although induced strongly following activation. Deficiency of CD15 causes the clinical disorder Leukocyte Adhesion Deficiency Type 2.


Diagnostic Use
  • In histopathology CD15 is important in the recognition of the Redd Sterberg cells of Hodgkin Lymphoma
  • CD15 is expressed by most cases of AML that have granulocytic or monocytic differentiation where expression may vary within the population.
  • CD15 should not however be regarded as an exclusive myeloid marker since it is expressed by some cases of CLL and ALL